National Ozempic shortage impacting people with diabetes especially in regional Australia | ABC News
It's one of the most talked about drugs on the internet and in Australia, but the booming popularity of Ozempic has left many people living with type 2 diabetes without access to the drug. Ozempic, a brand of anti-diabetic medicine called semaglutide, supplied by Danish company Novo Nordisk, has boomed in popularity world-wide in recent years as a weight-loss drug, including in Australia. The medication has been subsidised under Australia's Pharmaceutical Benefits Scheme since mid-2020. Although Australia's pharmaceutical regulator, the Therapeutic Goods Administration (TGA), has only approved Ozempic for treating adults with type 2 diabetes, the regulator can't stop doctors prescribing it for other health conditions — including weight loss. The TGA said the supply of Ozempic will be "limited" at least until the end of 2025 and has advised health professionals to inform patients of supply issues when prescribing the drug. Another semaglutide product, Wegovy, can also be prescribed for weight loss — but unlike Ozempic, it isn't subsidised by the PBS, making it significantly more expensive to obtain.
By Olivana Lathouris for ABC News Northern Territory.
Subscribe: http://ab.co/1svxLVE
Read more here: https://www.abc.net.au/news/20....25-02-05/australia-o
ABC News provides around the clock coverage of news events as they break in Australia and abroad. It's news when you want it, from Australia's most trusted news organisation.
For more from ABC News, click here: https://ab.co/2kxYCZY
Watch more ABC News content ad-free on ABC iview: https://ab.co/2OB7Mk1
Go deeper on our ABC News In-depth channel: https://ab.co/2lNeBn2
Like ABC News on Facebook: http://facebook.com/abcnews.au
Follow ABC News on Instagram: http://instagram.com/abcnews_au
Follow ABC News on X (Twitter): http://twitter.com/abcnews
Note: In most cases, our captions are auto-generated.
#ABCNews #ABCNewsAustralia #ABCNewsNT